AF
AFJK.US Aimei Health Technology Co., Ltd Ordinary Share
- Market cap
- USD 39.3M
- P/E
- 177.3x
- P/B
- 4.83x
- ROE
- -0.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is AFJK.US undervalued?
Graham numberThe Graham number of Aimei Health Technology Co., Ltd Ordinary Share cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Aimei Health Technology Co., Ltd Ordinary Share fundamental analysis
No fundamental analysis for Aimei Health Technology Co., Ltd Ordinary Share yet.
Aimei Health Technology Co., Ltd Ordinary Share stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Aimei Health Technology Co., Ltd Ordinary Share
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New …
Full company profileAimei Health Technology Co., Ltd Ordinary Share financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Aimei Health Technology Co., Ltd Ordinary Share annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | - | 0.00 | 0.00 | 0.00 |
| Operating Income | -28.5K | -1.07M | -836K | -509K |
| EBITDA | 171K | -1.07M | -836K | -509K |
| Net Income | 171K | 2.55M | 1.06M | -75.4K |
| EPS | 0.02 | 0.28 | 0.26 | -0.07 |
| Balance Sheet | ||||
| Total Assets | 70.5M | 73.8M | 12.1M | 12.5M |
| Total Liabilities | 715K | 1.51M | 4.06M | 4.53M |
| Shareholders' Equity | 69.8M | 72.3M | 8.04M | 8.00M |
| Cash & Short-term Investments | 581K | 28.2K | 2.93K | 1.47K |
| Total Debt | - | 228K | 2.02M | 2.20M |
| Cash Flow | ||||
| Operating Cash Flow | - | -672K | -565K | -463K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | -672K | -565K | -463K |
| Ratios | ||||
| ROE | 0.2% | 3.5% | 13.2% | -0.9% |
| ROA | 0.2% | 3.5% | 8.8% | -0.6% |
| Debt to Equity | - | 0.00x | 0.25x | 0.27x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Aimei Health Technology Co., Ltd Ordinary Share dividends
Aimei Health Technology Co., Ltd Ordinary Share has not paid dividends in the last 3 fiscal years.
Who owns Aimei Health Technology Co., Ltd Ordinary Share
- Insiders 64.97%
- Institutions 31.96%
- Public & others 3.08%
- Shares outstanding 3.17M
- Free float 1.11M
Top funds holding AFJK.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 5.81K | 0.18% | 0.00% | Aug 2026 |
Top institutions holding AFJK.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| First Trust Capital Management L.P. | 680K | 21.48% | 0.00% | Jun 2026 |
| Glazer Capital, LLC | 134K | 4.22% | 0.00% | Jun 2026 |
| Clear Street Group Inc | 83.3K | 2.63% | 0.00% | Jun 2026 |
| Karpus Management Inc | 77.1K | 2.44% | 0.00% | Jun 2026 |
| SBI Securities Co Ltd | 112.00 | 0.00% | 0.00% | Jun 2026 |
| UBS Group AG | 59.00 | 0.00% | +321.43% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 43.00 | 0.00% | -14.00% | Jun 2026 |
| Federation des caisses Desjardins du Quebec | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Advisor Group Holdings, Inc. | 0.00 | 0.00% | -100.00% | Jun 2026 |
Aimei Health Technology Co., Ltd Ordinary Share company profile
- Company name
- Aimei Health Technology Co., Ltd Ordinary Share
- Ticker
- AFJK.US
- ISIN
- KYG013411098
- Exchange
- USA Stocks
- Listed since
- Jan 22, 2024
- Sector
- Financial Services
- Industry
- Life Sciences Tools & Services
- Fiscal year end
- December
- Address
- 10 East 53rd Street, New York, NY, United States, 10022
- Phone
- 861 375 8131392
- Website
- -
About Aimei Health Technology Co., Ltd Ordinary Share
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd Ordinary Share management
2- Mr. Junheng XieCEO, Secretary & Director · born 1989
- Mr. Heung Ming WongCFO & Director · born 1969